Latest Breaking News On - Alnylam pharmaceuticals life sciences - Page 1 : comparemela.com

Revenue of $265 Million, up 5% Year-Over-Year, up 8% in Constant Currency, Exceeds Guidance GAAP Operating Margin of 6.8% and Non-GAAP Operating Margin of 26.6%, Exceeds Guidance GAAP Net Income.

Ukraine
Israel
Canada
United-states
Russia
Japan
United-kingdom
Idaho
Japanese
American
Aaron-levie
Dylan-smith